Why there are fewer barriers to CAR-T in Spain than in the U.S.

A special European policy allows researchers at hospitals to make their own advanced cell or gene therapies under particular circumstances.

December 19, 2023 Check out STAT+

Sponsored By

Mike Reddy for STAT STAT+ | In the U.S., scientists see barriers to the development of CAR-T cell therapies. In Spain, a hospital brews its own Under a special European policy, the CAR-T won regulatory approval and was reimbursed by the national health system. By Andrew Joseph STAT+ | Amy Abernethy to step down as Verily's chief medical officer in latest departure from company Amy Abernethy was seen as a key figure in providing direction to Verily, known in its early years known for the haziness of its mission. By Matthew Herper U.S. government spent more on health care in 2022 than six countries with universal health care combined More taxpayer dollars go to health care in the U.S. than in countries with single-payer systems. CMS study says 41% of all health care spending is public. By Annalisa Merelli Hyacinth Empinado/STAT STAT+ | Here are the worst biopharma CEOs of 2023 Pfizer is this year's anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourla is the worst. By Adam Feuerstein STAT+ | Health care industry fights back against crackdowns on health data tracking Providers say regulators have overstepped their authority and hobbled critical health care infrastructure by targeting data trackers. By Katie Palmer Opinion: There's a public health crisis lurking in our data: the Census option 'some other race' Nearly 50 million people in the 2020 Census chose "some other race." That imprecise data is hurting public health. By Juan Carlos Gonzalez Jr. Adobe What the new health counsels at FTC, DOJ, and HHS might do Three major government agencies, FTC, DOJ, and HHS, are adding new officials to investigate price-gouging in health care. By Brittany Trang

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser